OPTIMIZERx

Yahoo Finance • 18 days ago

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) an... Full story

Yahoo Finance • 18 days ago

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar’s Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Optimiz... Full story

Yahoo Finance • 22 days ago

OptimizeRx Corp (NASDAQ:OPRX) Combines Technical Strength with High-Growth Momentum

In the world of growth investing, combining technical strength with fundamental momentum can be a good method for finding high-potential stocks. The method used here brings together Mark Minervini’s Trend Template, a strict group of techni... Full story

Yahoo Finance • last month

Stock Market Today: Nasdaq Up, S&P 500 Etches Record High As Lumentum Soars; Nvidia Ends Well Off Lows (Live Coverage)

The Nasdaq leads upside with a moderate gain while the S&P 500 hits an all-time high. Nvidia trims losses bullishly; Pure Storage executes a breakaway gap. Continue Reading View Comments... Full story

Yahoo Finance • last month

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and... Full story

Yahoo Finance • 2 months ago

OptimizeRX price target raised to $20 from $14 at JMP on strong earnings

Investing.com - JMP Securities raised its price target on OptimizeRX (NASDAQ:OPRX) to $20.00 from $14.00 on Monday, while maintaining a Market Outperform rating following the company’s strong second-quarter results. According to InvestingP... Full story

Yahoo Finance • 2 months ago

OptimizeRx raises 2025 revenue guidance to $104M-$108M as contracted revenue climbs 30%

Earnings Call Insights: OptimizeRx Corporation (OPRX) Q2 2025 MANAGEMENT VIEW * CEO Stephen L. Silvestro opened the call highlighting that "Q2 revenues increasing 55% year-over-year to $29.2 million, with adjusted EBITDA coming in at $... Full story

Yahoo Finance • 2 months ago

OptimizeRx Corp (NASDAQ:OPRX) Surges 15% After Blowout Q2 Earnings and Raised 2025 Guidance

OptimizeRx Corp. (NASDAQ:OPRX [https://www.chartmill.com/stock/quote/OPRX]) reported second-quarter 2025 financial results that significantly exceeded analyst expectations, driving a sharp positive reaction in after-hours trading. The heal... Full story

Yahoo Finance • 2 months ago

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Q2 revenue of $29.2 million, increased 55% year-over-yearQ2 gross profit increased 59% year-over-year to $18.6 millionPaid down $4.5 million of principal on outstanding term loan during Q2Increased full year 2025 guidance to a revenue rang... Full story

Yahoo Finance • 2 months ago

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and... Full story

Yahoo Finance • 3 months ago

OptimizeRx appoints CEO Steve Silvestro to board of directors

WALTHAM, Mass. - OptimizeRx Corp. (NASDAQ:OPRX), a healthcare technology company with a market capitalization of $240 million and impressive year-to-date returns of 167%, has appointed its Chief Executive Officer Steve Silvestro to its Boa... Full story

Yahoo Finance • 3 months ago

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and... Full story

Yahoo Finance • 3 months ago

Simulmedia & OptimizeRx partner to bring Micro-Neighborhood® targeting to TV & streaming

[Businessmen making handshake with partner, greeting, dealing, merger and acquisition, business cooperation concept, for business, finance and investment background, teamwork and successful business] Tippapatt Simulmedia, a leader in data... Full story

Yahoo Finance • 4 months ago

OptimizeRx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and... Full story

Yahoo Finance • 5 months ago

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and... Full story

Yahoo Finance • 5 months ago

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) an... Full story

Yahoo Finance • 7 months ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%Company generated revenue from 48 DAAP deals in 2024, up from 24 in 2023 WALTHAM, Mass., March... Full story

Yahoo Finance • 7 months ago

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) an... Full story

Yahoo Finance • 7 months ago

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

WALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) an... Full story

Yahoo Finance • 7 months ago

OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and... Full story